About

Coronary artery disease (CAD) is one of the most common causes of death worldwide. It is responsible for one-third of deaths in people over 35 years old, with the percentage reaching close to 50% (according to some estimates) in western countries.

The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD & .There has been significant progress made in developing novel strategies for patients suffering from CAD and its associated complications. These strategies have ranged from drugs to robotic surgery to nanotechnology.

Articles

Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Inhibition in Patients With or at High Risk of Coronary Heart Disease

Citation:

US Cardiology Review 2017;11(1):16–7

Guest Editorial: Commentary on the Findings of the GLAGOV Randomized Clinical Trial

Citation:

US Cardiology Review 2017;11(1):18–9

Guest Editorial: A Brave New World for Non-vitamin K Antagonist Oral Anticoagulants: Have We seen the Last of Warfarin?

Citation:

US Cardiology Review 2017; 11(1):37–8

Dual Anti-platelet Therapy after Coronary Stenting: Rationale for Personalized Duration of Therapy

Citation:

US Cardiology Review 2017;11(1):31–6